You are here: Home > Institute of Excellence (CPD) > CPD Events > Do No (Ocular Surface) Harm: How to Uncover Iatrogenic Dry Eye

Do No (Ocular Surface) Harm: How to Uncover Iatrogenic Dry Eye

Available from: 1/09/2025 (AEST)

Where to publish: https://lms.optometry.org.au/course/view.php?id=931

Provider: Mivision

Activity Outline

Dr Ally Xue and Helen Gleave discuss the causes of iatrogenic dry eye and how you can mitigate their adverse effects on the ocular surface to improve patient quality of life.
Dry eye disease (DED) is a multifactorial disorder of the ocular surface, characterised by a loss of tear film homeostasis and accompanied by ocular symptoms such as discomfort, visual disturbance, and poor tear film stability.1 Based on the predominant underlying disease mechanisms, DED is traditionally classified into two main subtypes – aqueous-deficient dry eye (ADDE) and evaporative dry eye (EDE).1 But regardless of aetiology, both forms perpetuate a vicious cycle of tear film instability and hyperosmolarity, ultimately leading to ocular surface inflammation.

Learning Objectives

  • Be able to identify common causes of iatrogenic dry eye
  • Know how to mitigate their adverse effects on the ocular surface
  • Recognise the influence of blinking patterns and East Asian eyelid morphology on dry eye
  • Be aware of the role of hyaluronic acid in commercial eye drop formulations and its implication for iatrogenic dry eye

Max CPD hours awarded: 1.25

Session Information

Name
Do No (Ocular Surface) Harm: How to Uncover Iatrogenic Dry Eye
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1.25

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.